Screener
60 Degrees Pharmaceuticals SXTP Q1 2026 earnings
Reported May 15, 2026 · Before market open
Revenue$162.1KMiss by $117.9K
EPS-$1.28Miss by $0.52
Revenue estimate$280.0K
EPS estimate-$0.76
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$270.0K
EPS estimate-$0.61
Versus estimates
Revenue
Diluted EPS
FAQ
- When did 60 Degrees Pharmaceuticals report Q1 2026 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were 60 Degrees Pharmaceuticals's Q1 2026 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $162.1K and eps of $-1.28 for Q1 2026.
- Did 60 Degrees Pharmaceuticals beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $280.0K by $117.9K. EPS missed the consensus estimate of $-0.76 by $0.52.
- How did 60 Degrees Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.9% from $163.6K a year earlier and eps grew 17.9% from $-1.56.
- Where can I find 60 Degrees Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001554855-26-001058) directly on SEC EDGAR. The filing index links above go to sec.gov.
